The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitro studies
Open accessAbstract
Hoe 140 (d‐Arg‐[Hyp 3, Thi 5,d‐Tic 7, Oic 8]bradykinin) is a new bradykinin (BK)‐antagonist. It was tested in several in vitro assays and compared with d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK. In receptor binding studies in guinea‐pig ileum preparations, Hoe 140 showed an IC 50 of 1.07 × 10−9 mol l−1 and a KI value of 7.98 × 10−10 mol l−1. In isolated organ preparations Hoe 140 and d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK inhibited bradykinin‐induced contractions concentration dependently, with IC 50‐values in the guinea‐pig ileum preparation of 1.1 × 10−8 mol l−1 and 3 × 10−5 mol l−1, respectively. pA 2 values in this tissue were 8.42 and 6.18, respectively. In the rat uterus preparation the IC 50 value was 4.9 × 10−9 mol l−1 for Hoe 140.d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK showed an IC 50 of 4.0 × 10−6 mol l−1. The IC 50 values in the guinea‐pig isolated pulmonary artery were 5.4 × 10−9 mol l−1 and 6.4 × 10−6 mol l−1, respectively. In the rabbit aorta no inhibitory effects on Des‐Arg 9‐BK induced contractions were observed. In cultured bovine endothelial cells, Hoe 140 antagonized (IC 50= 10−8 mol l−1) bradykinin‐induced endothelium‐derived relaxing factor (EDRF) release and the bradykinin‐induced increase in cytosolic free calcium (IC 50= 10−9 mol l−1). Hoe 140 (10−7 mol l−1) totally suppressed the bradykinin‐induced (10−8 to 10−4 mol l−1) prostacyclin (PGI 2) release from cultured endothelial cells of bovine aorta.d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK (10−7 mol l−1) showed a weaker antagonism. Taken together these results show that Hoe 140 is a highly potent bradykinin antagonist. It was two to three orders of magnitude more potent than d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
(1985) · International Journal of Biochemistry · doi:10.1016/0020-711x(85)90098-9 · Cited by 3,478
Tsien, R. Y., Pozzan, T., & Rink, T. J. (1982) · The Journal of cell biology · doi:10.1083/jcb.94.2.325 · Cited by 2,244
Pharmacology of bradykinin and related kinins.
Regoli, D., & Barabé, J. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06836-x · Cited by 1,892
Sachs, L. (1984) · Springer eBooks · doi:10.1007/978-3-662-05748-3 · Cited by 638
Competitive antagonists of bradykinin
Vavrek, R. J., & Stewart, J. M. (1985) · Peptides · doi:10.1016/0196-9781(85)90033-6 · Cited by 463
Steranka, L. R., Manning, D. C., DeHaas, C. J., Ferkany, J. W., Borosky, S. A., Connor, J. R., Vavrek, R. J., Stewart, J. M., & Snyder, S. H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3245 · Cited by 400
The granulation of ternary mixtures: the effect of the solubility of the excipients
Jaiyeoba, K. T., & Spring, M. S. (1980) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1980.tb12833.x · Cited by 323
New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization
Regoli, D., Rhaleb, N.-E., Dion, S., & Drapeau, G. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90067-i · Cited by 164
D’Orléans-Juste, P., Nucci, G. D., & Vane, J. R. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11903.x · Cited by 115
Cited by
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
Mundel, P., Reiser, J., Borja, A. Z. M., Pavenstädt, H., Davidson, G. R., Kriz, W., & Zeller, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3739 · Cited by 877
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivo studies
Wirth, K., Hock, F. J., Albus, U., Linz, W., Alpermann, H. G., Anagnostopoulos, H., Henke, S., Breipohl, G., König, W., Knolle, J., et al. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12249.x · Cited by 830
Self-citationInflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Metadata
- Authors
- Hock, F. J., Wirth, K., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., König, W., Knolle, J., & Schölkens, B. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1991-03
- Volume
- 102
- Issue
- 3
- Pages
- 769-773
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W4244444868
- Cited by
- 613
- References
- 11
- FWCI
- 30.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitro studies. https://app.cochat.ai/papers/10.1111/j.1476-5381.1991.tb12248.x
- The paper
- Hock, F. J., Wirth, K., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., König, W., Knolle, J., & Schölkens, B. A. (1991). Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitro studies. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1991.tb12248.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.